Potential Drug Target: SLC35F1 Gene (G222553)

Target Name: SLC35F1

NCBI ID: G222553

SLC35F1

Potential Drug Target: SLC35F1 Gene

SLC35F1, also known as SLC35F1 gene or SLC35F1 protein, is a member of the Sodium Chloride Transporter (SLC) family 35. It is a cDNA gene that encodes a protein known as F1. The SLC family is a large gene family that has been identified as potential drug targets due to their involvement in various physiological processes in the body. SLC35F1 is a potential drug target because of its role in the regulation of salt and water balance, which is crucial for maintaining the health and function of the body.

The SLC35F1 gene is located on chromosome 12q34 and has been shown to encode a protein with multiple functions. One of its main functions is to regulate the intake and excretion of sodium and water into the body. This is critical for maintaining the proper levels of sodium in the body, which is essential for various physiological processes such as muscle and nerve function, nerve signaling, and the regulation of blood pressure.

SLC35F1 is a transmembrane protein, which means that it spans the cell membrane and is involved in the regulation of the movement of molecules into and out of the cell. This is important for maintaining the stability of the cell and for the delivery of various substances into and out of the cell. The SLC35F1 gene has been shown to encode a protein that is involved in the regulation of the transport of Na+ and water into the body.

SLC35F1 is also involved in the regulation of the balance between the intake and excretion of water and electrolytes, which is important for maintaining the proper levels of water and salt in the body. This is critical for maintaining the body's water balance, which is essential for various physiological processes such as muscle and nerve function, and for maintaining the proper functioning of the body's cells.

In addition to its role in the regulation of salt and water balance, SLC35F1 is also involved in the regulation of the body's electrolyte levels. Electrolytes are essential for the proper functioning of the body's cells and tissues, and they play a critical role in maintaining the body's electrical balance. SLC35F1 is shown to be involved in the regulation of the balance between the intake and excretion of electrolytes, which is important for maintaining the proper levels of sodium, potassium, magnesium, and other electrolytes in the body.

SLC35F1 is also involved in the regulation of the body's blood pressure. Blood pressure is critical for maintaining the proper functioning of the body's cells and tissues, and it is important for maintaining the blood flow to the body's tissues. SLC35F1 is shown to be involved in the regulation of the blood pressure, as it has been shown to encode a protein that is involved in the regulation of sodium and water intake and the delivery of electrolytes into the body.

SLC35F1 is also involved in the regulation of the body's triglyceride levels. Triglycerides are a type of fat that is stored in the body and can contribute to the development of various health conditions, such as heart disease and diabetes. SLC35F1 is shown to be involved in the regulation of triglyceride levels, as it has been shown to encode a protein that is involved in the regulation of sodium and water intake and the delivery of electrolytes into the body.

In conclusion, SLC35F1 is a potential drug target due to its role in the regulation of salt and water balance, which is crucial for maintaining the health and function of the body. The SLC35F1 gene has been shown to encode a protein with multiple functions, including

Protein Name: Solute Carrier Family 35 Member F1

Functions: Putative solute transporter

The "SLC35F1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC35F1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets